MyFinsight
Home
Blog
About
Contact
Cash and cash
equivalents
$229,136K
Marketable securities
$50,632K
Prepaid expenses and
other current assets
$5,256K
Total current assets
$285,024K
Operating lease
right-of-use assets
$4,881K
Other assets
$2,500K
Restricted cash
equivalents
$986K
Property and equipment,
net
$212K
Total assets
$293,603K
Total liabilities and
stockholders' equity
$293,603K
Total stockholders'
equity
$273,161K
Total liabilities
$20,442K
Accumulated deficit
-$792,711K
Additional paid-in capital
$1,065,621K
Total current
liabilities
$15,966K
Operating lease
liabilities, net of current...
$4,476K
Accumulated other
comprehensive income
$240K
Common stock, 0.0001
par value...
$11K
Accrued expenses
$11,282K
Accounts payable
$3,529K
Operating lease
liabilities, current portion
$1,155K
Back
Back
Balance Sheet
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)
source: myfinsight.com